CYTR Related New Coverage
-
Rodman & Renshaw Starts CytRx Corp (CYTR) at Market Outperform
-
Roth Capital Reinstates Coverage on CytRx Corp (CYTR) at Buy
-
Roth Capital Initiates Coverage on Biotechnology and Drugs Stocks
-
Merriman Curhan Ford Initiates Coverage on CytRx Corporation (CYTR) with a Buy
-
Brean Murray Initiates CytRx Corp. (CYTR) with a Buy
-
CE Unterberg Towbin initiates coverage on Rosetta Genomics (ROSG) at Buy
-
Rodman & Renshaw Started CYTR at Outperform
Back to CYTR Stock Lookup
